Mutations of TP53 are found in 4–37% of CLL patients, generally occur within the DNA-binding motifs (exons 4–8), and have been associated with very poor prognosis in several studies29,30. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.